SEC Form 4 · accession 0001093557-17-000074

DEXCOM INC · DXCM

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — SVP, Operations

Period of report

Mar 10, 2017

Accepted (ET)

Mar 14, 2017 · 7:58 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001093557

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1,F2	Mar 10, 2017	J	8,334	$78.24	D	75,153	D
Common Stock^F1,F2	Mar 10, 2017	J	6,667	$78.24	D	68,486	D
Common Stock^F1,F2	Mar 10, 2017	J	11,000	$78.24	D	57,486	D
Common Stock^F1,F3	Mar 10, 2017	J	8,334	$78.24	A	58,890	I	by Trust
Common Stock^F1,F3	Mar 10, 2017	J	6,667	$78.24	A	65,557	I	by Trust
Common Stock^F1,F3	Mar 10, 2017	J	11,000	$78.24	A	76,557	I	by Trust
Common Stock^F4,F3	Mar 10, 2017	D	3,213	$77.5506	D	73,344	I	by Trust
Common Stock^F4,F3	Mar 10, 2017	D	2,867	$77.5506	D	70,477	I	by Trust
Common Stock^F4,F3	Mar 10, 2017	D	5,813	$77.5506	D	64,664	I	by Trust

No Table II lines on this filing.

F1Shares were transferred from direct ownership to ownership under the Moy Family Trust upon vesting of previously awarded restricted stock units.
F2Included in this number are 57,216 unvested restricted stock units, 21,883 of which were granted on March 8, 2017 and shall vest through March 8, 2020, 22,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019 and 13,333 of which were granted on March 8, 2015 and shall vest through March 08, 2018.
F3Shares are held by the Moy Family Trust U/A/D 12/09/2013, with respect to which the reporting person is a trustee.
F4These shares were sold to cover the Company's tax withholding obligation that accrued in connection with the vesting of restricted stock units previously granted.